Early-effect of bariatric surgery (Scopinaro method) on intestinal hormones and adipokines in insulin resistant wistar rat

Journal of Physiology and Pharmacology

Volumn 64, Issue 5, 2013, Pages 571-577

  Dib, N ^a   Kiciak, A ^a   Pietrzak, P ^b   Ferenc, K ^b   Jaworski, P ^a   Kapica, M ^c   Tarnowski, W ^a   Zabielski, R ^b  

^a Orlowski Hospital Warsaw   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Apelin; Bariatric surgery; Diabetes type 2; Glucagon like peptide 1; Glycemic index; Insulin; Obesity; Polypeptide YY

Indexed keywords

ADIPOCYTOKINE; APELIN; GASTROINTESTINAL HORMONE; GHRELIN; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BARIATRIC SURGERY; CONTROLLED STUDY; DUODENUM MUCOSA; GLYCEMIC INDEX; HORMONE BLOOD LEVEL; IMMUNOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; NONHUMAN; RAT; WISTAR RAT;

ADIPOKINES; ANIMALS; BARIATRIC SURGERY; CYTOKINES; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEPTIDE YY; RATS; RATS, WISTAR;

EID: 84888258861     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev 2012; 13: 316-328.
2. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes - a systematic review. Diabetes Metab Res Rev 2004; 20: 438-445.
3. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
4. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236-242.
5. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
6. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopancreatic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 2011; 235: 699-703.
7. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006; 9: 497-507.
8. Koopmans HS, Sclafani A. Control of body weight by lower gut signals. Int J Obes 1981; 5: 491-495.
9. Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am 2007; 91: 393-414.
10. Murri M, Garcia-Fuentes E, Garcia-Almeida JM, et al. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg 2010; 20: 363-368.
11. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008; 34: 2-11.
12. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 2004; 55: 137-154.
13. Zabielski R, Dardillat C, Le Huerou-Luron I, Bernard C, Chayvialle JA, Guilloteau P. Periodic fluctuations of gut regulatory peptides in phase with the duodenal migrating myoelectric complex in preruminant calves: effect of different sources of dietary protein. Br J Nutr 1998; 79: 287-296.
14. Matyjek R, Herzig KH, Kato S, Zabielski R. Exogenous leptin inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats. Regul Pept 2003; 114: 15-20.
15. Kapica M, Laubitz D, Puzio I, Lubanska A, Zabielski R. The ghrelin pentapeptide inhibits the secretion of pancreatic juice in rats. J Physiol Pharmacol 2006; 54: 691-700.
16. Kapica M, Zabielska M, Puzio I, et al. Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats - preliminary results. J Physiol Pharmacol 2007; 58: 123-130.
17. Kapica M, Jankowska A, Antushevich H, et al. The effect of exogenous apelin on the secretion of pancreatic juice in anaesthetized rats. J Physiol Pharmacol 2012; 63: 53-60.
18. Goktas Z, Moustaid-Moussa N, Shen CL, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013; 10: 69. doi: 10.3389/fendo.2013.00069.
19. Sun G, Bishop J, Khalili S, et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007; 85: 399-404.
20. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010; 2010: 513948. doi: 10.1155/2010/513948.
21. Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J, et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity 2007; 15: 2391-2395.
22. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397-1403.
23. Han D-H, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997; 46: 1761-1767.
24. Clegg DJ, Gotoh K, Kemp C, et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav 2011; 103: 10-16.
25. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618-620.
26. Cagigas JC, Martino E, Escalante CF, et al. Technical alternatives in laparoscopic distal gastric bypass for morbid obesity in a porcine model. Obes Surg 1999; 9: 166-170.
27. Horner KM, Byrne NM, Cleghorn GJ, Naslund E, King NA. The effect of weight loss strategies on gastric emptying and appetite control. Obes Rev 2011; 12: 935-951.
28. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 2003; 113: 217-221.
29. Yip S, Signal M, Smith G, et al. Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction. Obes Surg 2013; Aug 10. (epub ahead of print).
30. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine upregulated by insulin and obesity. Endocrinology 2005; 146: 1764-1771.
31. Soriguer, F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009; 19: 1574-1580.
32. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 2007; 17: 1193-1198.
33. Stratis C, Alexandrides T, Vagenas K, Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 2006; 16: 752-758.
34. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780-785.
35. Boey D, Heilbronn L, Sainsbury A, et al. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 2006; 40: 317-324.
36. Botella-Carretero JI, Luque-Ramirez M, Alvarez-Blasco F, Peromingo R, San Millan JL, Escobar-Morreale HF. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 2008; 18: 1000-1006.
37. Friebe D, Neef M, Kratzsch J, et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT) /pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011; 54: 1200-1211.
38. Dogru T, Sonmez A, Tasci I, et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007; 76: 24-29.
39. Tatemoto K. Search for an endogenous ligand of the orphan G proteincoupled receptor-discovery of apelin, a novel biologically active peptide. Nihon Rinsho 2000; 58: 737-746.
40. Roberts RE, Glicksman C, Alaghband-Zadeh J, Sherwood RA, Akuji N, le Roux CW. The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol 2011; 74: 67-72.
41. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998; 26: 123-128.
42. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 2007; 92: 4052-4055.
43. Helou N, Obeid O, Azar ST, Hwalla N. Variation of postprandial PYY 3-36 response following ingestion of differing macronutrient meals in obese females. Ann Nutr Metab 2008; 52: 188-195.
44. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006; 4: 223-233.
45. Valentini L, Wirth EK, Schweizer U, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009; 25: 172-181.
46. Buldak RJ, Polaniak R, Buldak L, et al. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma ME45 cells. J Physiol Pharmacol 2013; 64: 377-385.
47. Furnes MW, Zhao CM, Stenstrom B, et al. Feeding behavior and body weight development: lessons from rats subjected to gastric bypass surgery or high-fat diet. J Physiol Pharmacol 2009; 60(Suppl. 7): 25-31.